Tender timing volatility in animal healthcare
Animal healthcare revenue fell 30% YoY due to delayed government tenders; recovery depends on timely rollout.
HESTERBIO / Q4-FY26 / risks
Keep the risk register visible.
Hester Biosciences · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
high
Rising raw material costs
Global geopolitical developments and supply chain disruptions are increasing raw material costs, pressuring margins.
High receivables and working capital
Receivables of ₹92 crore on ~₹300 crore revenue are elevated; Q4 sales spike contributed but management is working to reduce days.
Regulatory changes requiring additional capex
Evolving regulatory requirements may necessitate further capital allocation, though management did not quantify.